[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vertigo-benign-positional\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vertigo-benign-positional":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100650621","the-effect-of-chewing-gum-on-dizziness-in-patients-diagnosed-with-posterior-canal-benign-paroxysmal-positional-vertigo-in-the-emergency-department-100650621",false,"NCT07749573","The Effect of Chewing Gum on Dizziness in Patients Diagnosed With Posterior Canal Benign Paroxysmal Positional Vertigo in the Emergency Department","The Effect of Chewing Gum in Addition to Standard Treatment on Dizziness in Patients Diagnosed With Posterior Canal Benign Paroxysmal Positional Vertigo in the Emergency Department: A Randomized Controlled Clinical Trial","Inclusion Criteria:\n\n* Aged 18-65 years\n* Duration of dizziness complaint less than 24 hours\n* Posterior canal BPPV diagnosis confirmed by the emergency physician via the Dix-Hallpike test\n* Intravenous administration of 50 mg dimenhydrinate in 100 cc 0.9% NaCl initiated by the responsible emergency physician\n* Symptomatic dizziness with VAS ≥ 4\n* Alert, cooperative, and able to chew gum\n* Willingness to participate and provision of written informed consent\n\nExclusion Criteria:\n\n* Findings suggestive of central vertigo (vertical nystagmus, diplopia, ataxia, hemiparesis, focal neurological deficit, etc.)\n* Pregnancy\n* Known gum intolerance, history of allergy to gum or its excipients, temporomandibular joint dysfunction, significant tooth loss, use of dentures or removable prosthetics that would prevent chewing\n* Altered level of consciousness\n* Central pathology detected on investigations performed during the visit\n* Hemodynamic and\u002For respiratory instability\n* Diagnosis other than posterior canal BPPV as the cause of vertigo\n* Treatment other than pharmacological therapy planned or already administered by the responsible emergency physician\n* Active vomiting at the time of enrollment\n* Severe dizziness with VAS ≥ 8 (excluded due to high likelihood of requiring additional treatment, risk of protocol deviation, and safety concerns regarding gum chewing)\n* Patients who initially consented but subsequently wish to withdraw from the study","ALL","18 Years","65 Years",{"count":20,"type":21},88,"ESTIMATED","INTERVENTIONAL",[24],"NA","Dizziness is a common reason for emergency department visits. Posterior canal benign paroxysmal positional vertigo (BPPV) is one of the most frequent causes of peripheral vertigo. Intravenous dimenhydrinate is among the standard treatments administered in the emergency setting; however, this and similar drug classes may cause sedation and delay central compensation.\n\nThis study tests the hypothesis that chewing gum may modulate the vestibular system via trigeminal and cervical neuromuscular pathways, thereby reducing dizziness and nausea symptoms. Patients diagnosed with posterior canal BPPV who are started on intravenous dimenhydrinate will be randomly assigned to two groups: the intervention group will chew sugar-free mint-flavored gum for 20 minutes in addition to standard treatment, while the control group will receive standard treatment only. Dizziness and nausea severity will be assessed using VAS at baseline, 20 minutes, and 60 minutes.",[27,28],"Vertigo Benign Positional","Dizziness","NOT_YET_RECRUITING","2026-08-04",{"date":32,"type":33},"2026-08-06","ACTUAL",{"date":35,"type":21},"2026-09-01",{"date":37,"type":21},"2027-12-01",{"name":39,"class":40},"Ankara Ataturk Sanatorium Training and Research Hospital","OTHER_GOV",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":50,"minAge":17,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":22,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":4},"100635936","ai-chi-based-rehabilitation-for-peripheral-unilateral-vestibular-dysfunction-100635936","NCT07559162","Ai Chi-Based Rehabilitation for Peripheral Unilateral Vestibular Dysfunction","Contribution of an Ai Chi-Based Rehabilitation Program in Patients With Peripheral Unilateral Vestibular Dysfunction: A Randomized Prospective Single-Blind Study","AICHI-VR","Inclusion Criteria:\n\n* Age between 18 and 70 years\n* Diagnosis of unilateral peripheral vestibular hypofunction\n* Presence of dizziness symptoms for at least 3 months\n* Ability to participate in Ai Chi and aquatic exercise program\n* Berg Balance Scale score ≥21\n* Willingness to participate in the study\n\nExclusion Criteria:\n\n* Inability to complete assessment tests and questionnaires\n* Severe systemic disease that may interfere with exercise participation\n* Central vestibular disorders\n* Berg Balance Scale score ≤20\n* Severe visual or hearing impairment\n* Initiation or change of psychiatric medication within the last 3 weeks\n* Severe cardiopulmonary disease\n* Contraindications to hydrotherapy, including water phobia, behavioral disorders, dyspnea at rest, incontinence, known chlorine allergy, open wounds, acute systemic illness, epilepsy, tracheostomy, permanent drainage devices, immunodeficiency, or known neurological disorders","FEMALE","70 Years",{"count":53,"type":21},38,[24],"This study aims to evaluate the effects of an Ai Chi-based rehabilitation program on balance, dizziness severity, and quality of life in patients with unilateral peripheral vestibular hypofunction. Participants will be randomly assigned to either a control group receiving standard home-based vestibular rehabilitation exercises or an intervention group receiving additional Ai Chi sessions. The intervention will be conducted over a 4-week period with a total of 10 sessions under the supervision of a certified therapist.",[57,58,28,27,59,60],"Unilateral Peripheral Vestibular Hypofunction","Vestibular Disorders","Dizziness and Vertigo","Vestibular Function Disorder","2026-05-04",{"date":63,"type":33},"2026-05-07",{"date":65,"type":21},"2026-04-27",{"date":67,"type":21},"2026-07-27",{"name":69,"class":40},"Gaziosmanpasa Research and Education Hospital"]